These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7824783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
    Ghoshal S, Goda JS, Mallick I, Kehwar TS, Sharma SC.
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
    [Abstract] [Full Text] [Related]

  • 4. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A, Azria D, Pasche P, Stupp R, Chevalier J, Betz M, Mirimanoff RO, Ozsahin M.
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [Abstract] [Full Text] [Related]

  • 5. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.
    Allal AS, Taussky D, Mach N, Becker M, Bieri S, Dulguerov P.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1431-6. PubMed ID: 15050320
    [Abstract] [Full Text] [Related]

  • 6. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K, Tashiro M, Hosono M, Fukuda H, Takada Y, Kondo S, Inoue Y, Iguchi H, Kusuki M, Yamane H.
    Acta Otolaryngol Suppl; 2004 Oct 01; (554):62-6. PubMed ID: 15513514
    [Abstract] [Full Text] [Related]

  • 7. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thöni A, Ozsahin M, Bernier J, Töpfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C.
    J Clin Oncol; 2004 Dec 01; 22(23):4665-73. PubMed ID: 15534360
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
    Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E.
    Radiother Oncol; 2006 Apr 01; 79(1):34-8. PubMed ID: 16626826
    [Abstract] [Full Text] [Related]

  • 9. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
    Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ.
    Radiother Oncol; 2006 Mar 01; 78(3):306-12. PubMed ID: 16524634
    [Abstract] [Full Text] [Related]

  • 10. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P, Valavaara R, Aitasalo K, Kulmala J, Laine J, Elomaa L, Sillanmäki L, Minn H, Grénman R.
    Radiother Oncol; 2006 Feb 01; 78(2):146-51. PubMed ID: 16307813
    [Abstract] [Full Text] [Related]

  • 11. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
    Allal AS, Maire D, Becker M, Dulguerov P.
    Cancer; 2000 Feb 01; 88(3):648-52. PubMed ID: 10649260
    [Abstract] [Full Text] [Related]

  • 12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 13. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.
    Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161
    [Abstract] [Full Text] [Related]

  • 14. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G, Richetti A, Bignardi M, Corvo' R, Gabriele P, Sormani MP, Antognoni P.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):762-71. PubMed ID: 15708255
    [Abstract] [Full Text] [Related]

  • 15. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.
    Arch Otolaryngol Head Neck Surg; 2004 Jul 01; 130(7):861-7. PubMed ID: 15262764
    [Abstract] [Full Text] [Related]

  • 16. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM.
    Oral Oncol; 2008 Jul 01; 44(7):703-9. PubMed ID: 18061528
    [Abstract] [Full Text] [Related]

  • 17. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer.
    Nuyts S, Dirix P, Hermans R, Poorten VV, Delaere P, Weltens C, Van den Bogaert W.
    Head Neck; 2007 Aug 01; 29(8):720-30. PubMed ID: 17315171
    [Abstract] [Full Text] [Related]

  • 18. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 19. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ, Shakespeare TP, Thiagarajan A, Zhang X, Liang L, Tan S.
    Laryngoscope; 2005 May 01; 115(5):806-10. PubMed ID: 15867644
    [Abstract] [Full Text] [Related]

  • 20. Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
    Skladowski K, Hutnik M, Wygoda A, Golen M, Pilecki B, Przeorek W, Rutkowski T, Lukaszczyk-Widel B, Heyda A, Suwinski R, Tarnawski R, Maciejewski B.
    Int J Radiat Oncol Biol Phys; 2013 Mar 01; 85(3):741-6. PubMed ID: 22836063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.